PGEN

Precigen (PGEN)

About Precigen (PGEN)

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Details

Daily high

$4.37

Daily low

$4.07

Price at open

$4.30

52 Week High

$5.46

52 Week Low

$1.22

Market cap

1.5B

Dividend yield

0.00%

Volume

2.8M

Avg. volume

6.0M

P/E ratio

-2.97

Precigen News